Table: Zeria Pharm -2024/25 parent results
May 8 (Reuters)-
Zeria Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2025 Mar 31, 2024 Mar 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 34.71 34.02
(+2.0 pct) (+3.2 pct)
Operating 1.27 1.18
(+7.9 pct) (-34.4 pct)
Recurring 3.42 2.69
(+27.4 pct) (-1.9 pct)
Net 2.86 1.64
(+74.7 pct) (-24.2 pct)
EPS 64.86 yen 37.12 yen
Ann Div 47.00 yen 44.00 yen 48.00 yen
-Q2 Div 23.00 yen 22.00 yen 24.00 yen
-Q4 Div 24.00 yen 22.00 yen 24.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T